UniProt ID | ADHX_HUMAN | |
---|---|---|
UniProt AC | P11766 | |
Protein Name | Alcohol dehydrogenase class-3 | |
Gene Name | ADH5 {ECO:0000312|HGNC:HGNC:253} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 374 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Class-III ADH is remarkably ineffective in oxidizing ethanol, but it readily catalyzes the oxidation of long-chain primary alcohols and the oxidation of S-(hydroxymethyl) glutathione.. | |
Protein Sequence | MANEVIKCKAAVAWEAGKPLSIEEIEVAPPKAHEVRIKIIATAVCHTDAYTLSGADPEGCFPVILGHEGAGIVESVGEGVTKLKAGDTVIPLYIPQCGECKFCLNPKTNLCQKIRVTQGKGLMPDGTSRFTCKGKTILHYMGTSTFSEYTVVADISVAKIDPLAPLDKVCLLGCGISTGYGAAVNTAKLEPGSVCAVFGLGGVGLAVIMGCKVAGASRIIGVDINKDKFARAKEFGATECINPQDFSKPIQEVLIEMTDGGVDYSFECIGNVKVMRAALEACHKGWGVSVVVGVAASGEEIATRPFQLVTGRTWKGTAFGGWKSVESVPKLVSEYMSKKIKVDEFVTHNLSFDEINKAFELMHSGKSIRTVVKI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MANEVIKCK ------CCCCEEEEE | 22.38 | 19413330 | |
7 | 2-Hydroxyisobutyrylation | -MANEVIKCKAAVAW -CCCCEEEEEEEEEH | 34.55 | - | |
7 | Acetylation | -MANEVIKCKAAVAW -CCCCEEEEEEEEEH | 34.55 | 25953088 | |
7 | Ubiquitination | -MANEVIKCKAAVAW -CCCCEEEEEEEEEH | 34.55 | - | |
9 | Ubiquitination | ANEVIKCKAAVAWEA CCCEEEEEEEEEHHC | 34.09 | - | |
18 | Ubiquitination | AVAWEAGKPLSIEEI EEEHHCCCCCEEEEE | 50.24 | - | |
18 | Acetylation | AVAWEAGKPLSIEEI EEEHHCCCCCEEEEE | 50.24 | 26051181 | |
21 | Phosphorylation | WEAGKPLSIEEIEVA HHCCCCCEEEEEEEC | 36.16 | 113305849 | |
31 | Ubiquitination | EIEVAPPKAHEVRIK EEEECCCCCCEEEEE | 62.41 | - | |
84 | Ubiquitination | GEGVTKLKAGDTVIP CCCCCEECCCCEEEE | 52.45 | - | |
93 | Phosphorylation | GDTVIPLYIPQCGEC CCEEEEEECCCCCCC | 12.76 | 28152594 | |
97 | S-palmitoylation | IPLYIPQCGECKFCL EEEECCCCCCCCEEE | 4.09 | 29575903 | |
100 | S-palmitoylation | YIPQCGECKFCLNPK ECCCCCCCCEEECCC | 2.19 | 29575903 | |
101 | Acetylation | IPQCGECKFCLNPKT CCCCCCCCEEECCCC | 34.51 | 25953088 | |
101 | Ubiquitination | IPQCGECKFCLNPKT CCCCCCCCEEECCCC | 34.51 | - | |
103 | S-palmitoylation | QCGECKFCLNPKTNL CCCCCCEEECCCCCC | 1.88 | 29575903 | |
107 | Ubiquitination | CKFCLNPKTNLCQKI CCEEECCCCCCCCEE | 49.31 | - | |
107 | Acetylation | CKFCLNPKTNLCQKI CCEEECCCCCCCCEE | 49.31 | 26051181 | |
113 | 2-Hydroxyisobutyrylation | PKTNLCQKIRVTQGK CCCCCCCEEEEECCC | 31.33 | - | |
113 | Ubiquitination | PKTNLCQKIRVTQGK CCCCCCCEEEEECCC | 31.33 | 21890473 | |
113 | Acetylation | PKTNLCQKIRVTQGK CCCCCCCEEEEECCC | 31.33 | 25953088 | |
117 | Phosphorylation | LCQKIRVTQGKGLMP CCCEEEEECCCCCCC | 23.04 | 20068231 | |
120 | Malonylation | KIRVTQGKGLMPDGT EEEEECCCCCCCCCC | 38.77 | 26320211 | |
120 | Ubiquitination | KIRVTQGKGLMPDGT EEEEECCCCCCCCCC | 38.77 | - | |
123 | Sulfoxidation | VTQGKGLMPDGTSRF EECCCCCCCCCCEEE | 3.76 | 30846556 | |
127 | Phosphorylation | KGLMPDGTSRFTCKG CCCCCCCCEEEEECC | 24.90 | 20068231 | |
128 | Phosphorylation | GLMPDGTSRFTCKGK CCCCCCCEEEEECCC | 30.81 | 20068231 | |
131 | Phosphorylation | PDGTSRFTCKGKTIL CCCCEEEEECCCEEE | 16.52 | 20068231 | |
177 | Phosphorylation | CLLGCGISTGYGAAV EEECCCCCCCCCCCH | 10.89 | 28152594 | |
178 | Phosphorylation | LLGCGISTGYGAAVN EECCCCCCCCCCCHH | 32.28 | 28152594 | |
180 | Phosphorylation | GCGISTGYGAAVNTA CCCCCCCCCCCHHCC | 12.04 | 28152594 | |
186 | Phosphorylation | GYGAAVNTAKLEPGS CCCCCHHCCCCCCCC | 20.69 | 28152594 | |
226 | 2-Hydroxyisobutyrylation | IIGVDINKDKFARAK EEEEECCHHHHHHHH | 63.73 | - | |
226 | Ubiquitination | IIGVDINKDKFARAK EEEEECCHHHHHHHH | 63.73 | - | |
226 | Acetylation | IIGVDINKDKFARAK EEEEECCHHHHHHHH | 63.73 | 23236377 | |
228 | Ubiquitination | GVDINKDKFARAKEF EEECCHHHHHHHHHH | 42.40 | - | |
228 | Acetylation | GVDINKDKFARAKEF EEECCHHHHHHHHHH | 42.40 | 23749302 | |
233 | Succinylation | KDKFARAKEFGATEC HHHHHHHHHHCCCCC | 48.28 | - | |
233 | Succinylation | KDKFARAKEFGATEC HHHHHHHHHHCCCCC | 48.28 | 21890473 | |
233 | Ubiquitination | KDKFARAKEFGATEC HHHHHHHHHHCCCCC | 48.28 | 21890473 | |
247 | Phosphorylation | CINPQDFSKPIQEVL CCCHHHCCCCHHEEE | 45.90 | 25159151 | |
303 | Phosphorylation | ASGEEIATRPFQLVT ECCCCCCCCCEEEEE | 44.53 | 20058876 | |
310 | Phosphorylation | TRPFQLVTGRTWKGT CCCEEEEECCCCCCC | 29.55 | 24719451 | |
315 | Succinylation | LVTGRTWKGTAFGGW EEECCCCCCCCCCCC | 45.85 | - | |
315 | Succinylation | LVTGRTWKGTAFGGW EEECCCCCCCCCCCC | 45.85 | - | |
315 | Ubiquitination | LVTGRTWKGTAFGGW EEECCCCCCCCCCCC | 45.85 | - | |
315 | Acetylation | LVTGRTWKGTAFGGW EEECCCCCCCCCCCC | 45.85 | 30586761 | |
323 | Ubiquitination | GTAFGGWKSVESVPK CCCCCCCCCHHHHHH | 48.15 | 21890473 | |
324 | Phosphorylation | TAFGGWKSVESVPKL CCCCCCCCHHHHHHH | 25.30 | 28857561 | |
330 | Acetylation | KSVESVPKLVSEYMS CCHHHHHHHHHHHHC | 60.40 | 25953088 | |
330 | Ubiquitination | KSVESVPKLVSEYMS CCHHHHHHHHHHHHC | 60.40 | - | |
333 | Phosphorylation | ESVPKLVSEYMSKKI HHHHHHHHHHHCCCC | 33.18 | 26552605 | |
335 | Phosphorylation | VPKLVSEYMSKKIKV HHHHHHHHHCCCCCH | 10.13 | 29496907 | |
336 | Sulfoxidation | PKLVSEYMSKKIKVD HHHHHHHHCCCCCHH | 4.09 | 30846556 | |
337 | Phosphorylation | KLVSEYMSKKIKVDE HHHHHHHCCCCCHHH | 29.87 | 26552605 | |
338 | Ubiquitination | LVSEYMSKKIKVDEF HHHHHHCCCCCHHHH | 41.82 | - | |
338 | 2-Hydroxyisobutyrylation | LVSEYMSKKIKVDEF HHHHHHCCCCCHHHH | 41.82 | - | |
338 | Succinylation | LVSEYMSKKIKVDEF HHHHHHCCCCCHHHH | 41.82 | 23954790 | |
338 | Acetylation | LVSEYMSKKIKVDEF HHHHHHCCCCCHHHH | 41.82 | 25953088 | |
339 | Ubiquitination | VSEYMSKKIKVDEFV HHHHHCCCCCHHHHH | 40.22 | - | |
341 | Ubiquitination | EYMSKKIKVDEFVTH HHHCCCCCHHHHHHC | 53.14 | - | |
347 | Phosphorylation | IKVDEFVTHNLSFDE CCHHHHHHCCCCHHH | 15.46 | 28857561 | |
351 | Phosphorylation | EFVTHNLSFDEINKA HHHHCCCCHHHHHHH | 35.65 | 22167270 | |
357 | Acetylation | LSFDEINKAFELMHS CCHHHHHHHHHHHHC | 61.18 | 25038526 | |
357 | Ubiquitination | LSFDEINKAFELMHS CCHHHHHHHHHHHHC | 61.18 | - | |
362 | Sulfoxidation | INKAFELMHSGKSIR HHHHHHHHHCCCCEE | 1.54 | 21406390 | |
364 | Phosphorylation | KAFELMHSGKSIRTV HHHHHHHCCCCEEEE | 33.67 | 28857561 | |
366 | Ubiquitination | FELMHSGKSIRTVVK HHHHHCCCCEEEEEE | 45.80 | 19608861 | |
366 | Malonylation | FELMHSGKSIRTVVK HHHHHCCCCEEEEEE | 45.80 | 26320211 | |
366 | Acetylation | FELMHSGKSIRTVVK HHHHHCCCCEEEEEE | 45.80 | 23954790 | |
366 | 2-Hydroxyisobutyrylation | FELMHSGKSIRTVVK HHHHHCCCCEEEEEE | 45.80 | - | |
367 | Phosphorylation | ELMHSGKSIRTVVKI HHHHCCCCEEEEEEC | 22.34 | 28857561 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ADHX_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ADHX_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ADHX_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CHD3_HUMAN | CHD3 | physical | 16169070 | |
ADHX_HUMAN | ADH5 | physical | 12484756 | |
A4_HUMAN | APP | physical | 21832049 | |
CSK2B_HUMAN | CSNK2B | physical | 21988832 | |
ADHX_HUMAN | ADH5 | physical | 21988832 | |
ARNT_HUMAN | ARNT | physical | 21988832 | |
ERR1_HUMAN | ESRRA | physical | 21988832 | |
PRDX1_HUMAN | PRDX1 | physical | 21988832 | |
VTNC_HUMAN | VTN | physical | 21988832 | |
PQLC1_HUMAN | PQLC1 | physical | 21988832 | |
AL4A1_HUMAN | ALDH4A1 | physical | 26344197 | |
ESTD_HUMAN | ESD | physical | 26344197 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00898 | Ethanol |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Class III human liver alcohol dehydrogenase: a novel structural typeequidistantly related to the class I and class II enzymes."; Kaiser R., Holmquist B., Hempel J., Vallee B.L., Joernvall H.; Biochemistry 27:1132-1140(1988). Cited for: PROTEIN SEQUENCE OF 2-374. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-366, AND MASS SPECTROMETRY. |